Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1993 Apr;142(4):1163-72.

Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations

Affiliations
Comparative Study

Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations

A Scarpa et al. Am J Pathol. 1993 Apr.

Abstract

Eleven tumors of the ampulla of Vater (5 stage IV and 2 stage II adenocarcinomas, 1 stage II papillary carcinoma, 1 neuroendocrine carcinoma, and 2 adenomas, one with foci of carcinoma) were examined for Ki-ras and p53 gene mutations by single-strand conformation polymorphism analysis and direct sequencing of polymerase chain reaction-amplified DNA fragments. Ki-ras mutations were found in one adenocarcinoma and in the adenoma with foci of carcinoma, both involving mainly the intraduodenal bile duct component of the ampulla. Seven cases showed p53 gene mutations: four advanced-stage adenocarcinomas, the papillary carcinoma, the neuroendocrine carcinoma, and the adenoma with foci of carcinoma. Nuclear accumulation of p53 protein was immunohistochemically detected in the morphologically high-grade areas of the five cancers harboring a p53 gene missense point mutation. The adenomas, the two frame shift-mutated cancers, and the adenomatous and low-grade cancer areas of mutated carcinomas were immunohistochemically negative. Our data suggest that in ampullary neoplasia 1) p53 mutations are common abnormalities associated with the transformation of adenomas and low-grade cancers into morphologically high-grade carcinomas, and 2) Ki-ras mutations are relatively less frequent and might be restricted to tumors originating from the bile duct component of the ampulla.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 1991 Oct 15;51(20):5520-5 - PubMed
    1. Nature. 1991 Apr 4;350(6317):429-31 - PubMed
    1. Cancer Res. 1992 Jul 1;52(13):3674-8 - PubMed
    1. PCR Methods Appl. 1991 Aug;1(1):34-8 - PubMed
    1. Cell. 1989 Jun 30;57(7):1083-93 - PubMed

Publication types

Substances

LinkOut - more resources